The science behind the story: Following a cancer vaccine from concept to proof of concept | Broad Institute

The science behind the story: Following a cancer vaccine from concept to proof of concept | Broad Institute

BLOG / 07.6.17

The science behind the story: Following a cancer vaccine from concept to proof of concept

Credit : Susanna M. Hamilton, Broad Communications

By Tom Ulrich

The successful early-stage clinical trial of a personalized cancer vaccine for melanoma represents the culmination of almost a decade’s collaborative work to overcome challenges large and small.